DUBLIN, July 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4rvprn/ddimer_testing) has announced the addition of the "D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022" report to their offering.
At present, the in vitro diagnostics market is one of the fastest growing markets globally. This remarkable growth can be attributed to the improved health care awareness, preference of the people for preventive health checkups, accessibility to disease specific tests, and shift from manual to semi-automated and automated instruments. Diagnostic laboratories are facing challenges in delivering high-quality, efficient and timely testing solutions due to rising health care awareness and stringent regulations that put pressure on the health care budgets. This has led to growing adoption of automated solutions and new analyzers that deliver high throughput in lesser time and with enhanced efficiency. Point-of care testing has gained momentum in the past few years to meet the demand for quick turnaround time, thus accelerating reliable results. D-dimer assays and POC kits have been developed to confirm the exclusion of deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC).
The D-dimer testing market has been extensively analyzed on the basis of testing methods, applications, and geography. Testing methods include point-of-care testing (POC) and laboratory testing. Laboratory testing has been further segmented into coagulation analyzers and clinical chemistry analyzers. Applications comprise deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). Each of the segments has been analyzed in detail for market trends, number of D-dimer tests, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2014 to 2022, in terms of revenue in USD million and number of tests in million, considering 2012 and 2013 as the base years. The compound annual growth rate (%CAGR) for each market segment has been provided for the forecast period from 2014 to 2022 along with the estimations of market size.
The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., Bio/Data Corporation, Becton, Dickinson and Company, Corgenix, F. Hoffman-La Roche Ltd., Helena Biosciences, Siemens Healthcare, Sysmex Corporation, Thermo Fisher Scientific, and Trinity Biotech. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 D-dimer Testing Market Overview
Chapter 4 Global D-dimer Testing Market Revenue (USD Million) and No. of Tests (Million), by Testing Method, 2012 - 2022
Chapter 5 Global D-dimer Testing Market Revenue (USD Million) and Volume (No. of Tests in Millions), by Application, 2012 - 2022
Chapter 6 Global D-dimer Testing Market Revenue (USD Million) & Volume (No. of Tests in Millions), by Geography, 2012 - 2022
Chapter 7 Recommendations
Chapter 8 Company Profiles
- Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter, Inc. - Becton, Dickinson and Company - Bio/Data Corporation - Corgenix Medical Corporation - F. Hoffmann-La Roche Ltd. - Helena Biosciences - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc. - Trinity Biotech plc
For more information visit http://www.researchandmarkets.com/research/4rvprn/ddimer_testing
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets